ArticleFrontiers in pharmacology2021

The Public Health Insurance Coverage of Novel Targeted Anticancer Medicines in China-In Favor of Whom? A Retrospective Analysis of the Insurance Claim Data.

Mingshuang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.